There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer’s disease. Much of this stems from the fact that because the information gathered to date has been obtained using a multitude of differential approaches, conditions, formulations, timing and dosages of treatment, results are difficult to compare. In addition,… Read More »
Researchers hope the system can zero in on the right patients to enroll in clinical trials, to speed discovery of drug treatments. By Rob Matheson A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition… Read More »
Higher HDL (“good” cholesterol) levels seem to be linked to reduced Alzheimer’s risk in older individuals. High total cholesterol and triglycerides (dyslipidemia) and late-onset Alzheimer’s disease are highly prevalent in western societies. Approximately 1% of individuals age 65 to 69 years develop Alzheimer’s, with the prevalence increasing to over 60% for individuals older than 95… Read More »
Many people worry about becoming forgetful. They think forgetfulness is the first sign of Alzheimer’s disease. But not all people with memory problems have Alzheimer’s. Share this infographic and help spread the word about what memory problems are normal and not. Other causes for memory problems can include aging, medical conditions, emotional problems, mild cognitive… Read More »
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from Washington University School of Medicine in St. Louis and the German Center for Neurodegenerative Diseases in Germany. The findings,… Read More »